https://www.thebodypro.com/category/fda-approved-hiv-medications/tag/african-americans

The Latest

pulling back curtain

This Week in HIV Research: Life in the Integrase Era

Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.

By Barbara Jungwirth and Myles Helfand
many one dollar bills

This Week in HIV Research: As Pill Burden Drops, Pill Cost Rises

Feb. 6, 2020: HIV medication costs outpace inflation; HIV's role in attenuating childhood vaccinations; the challenges of researching effects of medications during pregnancy; the need for localized HIV interventions in the U.S.

By Barbara Jungwirth and Myles Helfand
Customer giving medical prescription to pharmacist

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.

By Larry Buhl
Pair of female feet on a bathroom scale

One Class of HIV Drugs Is Associated With Weight Gain. What's the Latest?

The question of whether INSTIs cause weight gain continues to be debated. This story draws together some research on which drugs are associated with weight gain or other metabolic changes.

By Sony Salzman
woman with doctor looking at prescription bottle

This Week in HIV Research: Every Prescription Can Use a Good Steward

Sept. 19, 2019: HIV antiretroviral stewardship plans in hospitals can save money -- and lives; demographic correlates of PrEP interruption; HIV and atrial fibrillation risk; cytopenias common, despite viral suppression.

By Barbara Jungwirth and Myles Helfand
Promo Image

Warfarin and ARVs: Impact of African-American Race and Ritonavir

The commonly prescribed anticoagulant warfarin is highly susceptible to interactions with antiretroviral mediated through CYP 2C9, 2C19, and/or 3A4 pathways, although data are limited.

This retrospective, case‐control (1:2) study compared the warfar...

By Simon Collins for HIV i-Base
ICAAC HIV Poster Roundup #1: Clinically Relevant Findings Img

ICAAC HIV Poster Roundup #1: Clinically Relevant Findings

Here's a quick sampling of some of the more noteworthy HIV-related posters presented at a major research conference last week. Topics covered include a surprisingly high frequency of people quitting Atripla due to side effects; the decline of multidr...

By Myles Helfand